Consultation responses

Search our registers

Main navigation

• What we do

  This section provides information on the functions and structure of the Society, covering: key documents about the Society and its history, the Society's business plan and annual review, the annual British Pharmaceutical Conference, meetings at the Society, people and structures, the Council and its work, devolution/national pharmacy boards, awards and scholarships, job vacancies at the Society, how to complain about the society.

• A career in pharmacy

  This section provides information on pharmacy careers, pharmacy education policy, undergraduate education including links to schools of pharmacy, preregistration training, the roles of pharmacy support staff, and working in other countries.

• Registration & support

  This section provides information on areas of support for the profession including registering with the Society, fee structure and payment of fees, updating personal details, clinical governance, audit resources, CPD, postgraduate courses and further training, leadership in pharmacy.

• Information resources

  This section covers the Society's information resources including the press office, library, advisory services, and museum; it also gives quick links to downloadable documents published by the Society.

  • News
  • Press office
  • Library
  • Advisory services
  • Museum
  • Download Society publications
    • Consultation responses
• World of pharmacy

  This section provides information on the wider world of pharmacy, covering: current developments in pharmacy, the use of medicines, science, practice research, working with other UK and international bodies, events and meetings.

• Professional leadership body

  This section provides information on the setting up of a new professional body for pharmacy, alongside a new regulatory body, as part of a fundamental modernisation of the pharmacy profession

The Society is frequently asked to respond to consultation documents by the government and a variety of non-governmental organisations. The Society's responses are available on this website, except on the rare occasions when the organisation which has issued the consultation asks for the document and the Society's response to be kept confidential.

These responses reflect the Society's policy or position on an issue. Their availability on the website is intended to provide information for the membership and to raise the Society's profile on national policy issues with external organisations.

Responses produced from 2004 to 2009 can be accessed below.

For further information on an individual response, please contact the Policy Development Division, which will put you in touch with the lead member of staff for that response:

Tel: 020 7572 2218
Fax: 020 7572 2506
e-mail: eleanor.lawton@rpsgb.org

Document title	Originator
October 2009
Public health intervention - school-based interventions to prevent smoking stakeholder comments	National Institute for Health and Clinical Excellence
Report to Ministers from the DH Steering Group on the Statutory Regulation of Practitioners of acupuncture, herbal medicine, traditional chinese medicine and other traditional medicine systems practised in the UK	Department of Health
Personal ownership of health records	Conservative Party
ARM 64 request to reclassify Galpharm non-drowsy hayfever and allergy relief tablets from pharmacy (P) to general sale list (GSL)	Medicines and Healthcare products Regulatory Agency
ARM 63 Request to reclassify a product from P to GSL Daktarin Intensiv	Medicines and Healthcare products Regulatory Agency
August 2009
MLX 358 The European Comission proposals on information to patients for prescription medicines	Medicines and Healthcare products Regulatory Agency
Views on the future of nursing & midwifery	Commission on the Future of Nursing and Midwifery
July 2009
Project on Primary Health Care for Socially Exluded Groups - Call for Evidence	Cabinet Office Department of Health
Medical profiling and online medicine: the ethics of 'personalised' healthcare in a consumer age	Nuffield Council on Bioethics
ARM 62 request to reclassify a product from P-GSL Lamisil Once 1% Cutaneous solution	Medicines and Healthcare products Regulatory Agency
June 2009
Patient safety - additional evidence	House of Commons Health Select Committee
The Office of the Health Professions Adjudicator Regulations 2009	Department of Health
The shared record professional guidance project - draft report	Royal College of General Practitioners Health Informatics Group
Reducing differences in the uptake of immunisations	National Institute for Health and Clinical Excellence
May 2009
ARM 61 Request to Reclassify a Product from POM to P Motilium 10	Medicines and Healthcare products Regulatory Agency
April 2009
Care Quality Commission reviews in 2009/10	Care Quality Commission
Depression in Adults (update): draft guideline consultation	National Institute for Health and Clinical Excellence
Concept paper on MHRA project to consolidate and review medicines legislation	Medicines and Healthcare products Regulatory Agency
March 2009
Public consultation (MLX 355): Proposals for changes to legislation and working procedures during an influenza pandemic	Medicines and Healthcare products Regulatory Agency
Secondary Care Electronic Prescribing Implementation Guidance	NHS Connecting for Health
MLX 357 – Consultation on measures to strengthen the medicines’ supply chain and reduce the risk from counterfeit medicines	Medicines and Healthcare products Regulatory Agency
The Pharmacy Order 2009 – proposals for consultation	Department of Health
February 2009
Alcohol	House of Commons Health Select Committee
MLX 356 Proposal for amendments to medicines legislation to allow mixing of medicines in palliative care	Medicines and Healthcare products Regulatory Agency
Auditing the Initial Stages of the Healthcare Regulatory Bodies' Fitness to Practise Procedures	Council for Healthcare Regulatory Excellence
Medicines adherence clinical guideline implementation support tools	National Institute for Health and Clinical Excellence
January 2009
DEFRA Consultation on proposed amendments to the Hazardous Waste (England and Wales) Regulations 2005 (joint response with other pharmacy bodies)	Department for Environment Food and Rural Affairs
Guidance on NHS patients who wish to pay for additional private care	Department of Health
Enquiry on the NHS Next Stage Review Final Report	House of Commons Health Select Committee
Health and social care studies	Audit Commission
Alcohol dependence and harmful alcohol use	National Institute for Health and Clinical Excellence
ARM 56 - Request to reclassify tamsulosin (Flomax Relief) from POM to P	Medicines and Healthcare products Regulatory Agency
Reform of health and social care complaints	Department of Health
December 2008
The purchase of additional drugs by NHS Patients ("top-up fees")	House of Commons Health Select Committee
Additional uses of patient data	NHS Connecting for Health
Improving the value of drug treatment systems	National Treatment Agency for Substance Misuse
Directive on the application of patients' rights in cross-border healthcare	Department of Health
November 2008
Patient safety	House of Commons Health Select Committee
Pharmacy in England: Building on strengths – delivering the future – proposals for legislative change (response from English Pharmacy Board)	Department of Health
Glaucoma guidelines	National Institute for Health and Clinical Excellence
MLX 351: Amendments to medicines legislation to allow dispensing opticians access to certain POMs	Medicines and Healthcare products Regulatory Agency
ARM 55 – Request to reclassify a product from P to GSL	Medicines and Healthcare products Regulatory Agency
October 2008
ARM 60 – Request to reclassify a product from P to GSL	Medicines and Healthcare products Regulatory Agency
ARM 59 – Request to reclassify a product from P to GSL	Medicines and Healthcare products Regulatory Agency
ARM 58 – Request to reclassify a product from P to GSL	Medicines and Healthcare products Regulatory Agency
ARM 57 – Request to reclassify a product from P to GSL	Medicines and Healthcare products Regulatory Agency
Public health information (English Pharmacy Board response)	All Party Parliamentary Group on Primary Care and Public Health
Review of NHS IT policy	Conservative Party
Revised standards of education and training	Health Professions Council
Safe sensible social - consultation on further action	Department of Health
September 2008
Inquiry into the European Commission’s proposed directive on the application of patients’ rights in cross-border healthcare	House of Lords EU Select Committee
MLX 348: Supply and administration of medicines by members of the Armed Forces	Medicines and Healthcare products Regulatory Agency
NHS resilience and business continuity management guidance (joint response with other pharmacy bodies)	Department of Health
Primary care federations: Putting patients first	Royal College of General Practitioners
Medicines concordance	National Institute for Health and Clinical Excellence
Advertising of medicine: draft guidance for consumer websites	Medicines and Healthcare products Regulatory Agency
Transforming the quality of dementia care (joint response with United Kingdom Psychiatric Pharmacy Group and College of Mental Health Pharmacists)	Department of Health
Future of tobacco control (joint response with Pharmaceutical Services Negotiating Committee)	Department of Health
August 2008
Consequences of additional private drugs for NHS care	Department of Health
Ideas and views on Asthma UK's development	Asthma UK
Wider release of NHS prescribing data	NHS Information Centre for Health and Social Care
ARM 54 – Request to reclassify a product from P to GSL	Medicines and Healthcare products Regulatory Agency
Mixing anthelmintic drenches for sheep before administration	Veterinary Medicines Directorate
July 2008
Distribution category review for sheep, multi-species, rabbit and fish vaccines for use in UK (updated)	Veterinary Medicines Directorate
Public health guidance: prevention of skin cancer	National Institute for Health and Clinical Excellence
Higher education at work: High skills; high values	Department for Innovation, Universities and Skills
June 2008
Review of the regulation of unlicensed medicines	Medicines and Healthcare products Regulatory Agency
Framework for the registration of health and adult social care providers	Department of Health
Benefits and risks of medical treatment	Association of the British Pharmaceutical Industry/ Long Term Conditions Alliance
Veterinary Medicines Regulations 2008	Veterinary Medicines Directorate
Framework for higher education qualifications in England, Wales and Northern Ireland	Quality Assurance Agency
Distribution category review	Veterinary Medicines Directorate
May 2008
ARM 53 – Request to reclassify a product from P to GSL	Medicines and Healthcare products Regulatory Agency
April 2008
Problems with infusions and sampling from arterial lines	National Patient Safety Agency
dm+d and medical gases	NHS Connecting for Health
ARM 52 – Request to reclassify a product from P to GSL	Medicines and Healthcare products Regulatory Agency
ARM 51 – Request to reclassify a product from POM to P	Medicines and Healthcare products Regulatory Agency
Legal proposal on information to patients	European Commission
Healthcare for London review	Joint Overview and Srutiny Committee
March 2008
Reducing dosage errors with opioid medicines	National Patient Safety Agency
Pandemic influenza preparedness programme, Adult clinical algorithm	Department of Health
NHS Direct application to become an NHS Foundation Trust	NHS Direct
Code of practice on good guidance on regulation	Department for Business Enterprise and Regulatory Reform
Code of practice for the pharmaceutical industry	Prescription Medicines Code of Practice Authority
Review of NICE Technology Appraisal Guidance No 84	National Institute for Health and Clinical Excellence
LGA Health Commission call for evidence (Joint response with other pharmacy bodies)	Local Government Association
Validation via provisional registration	General Dental Council
February 2008
Use and sharing of personal information in the public and private sectors	Data Sharing Review
Harmonising fitness to practise sanctions across regulators	Council for Healthcare Regulatory Excellence
Reducing differences in the uptake of immunisations	National Institute for Health and Clinical Excellence
Pandemic influenza: surge capacity and prioritisation in health services (Joint response with other pharmacy bodies)	Department of Health
Safeguarding Vulnerable Groups Act: Independent safeguarding authority scheme (Joint response with other pharmacy bodies)	Department for Children, Schools and Families
Possible amendments to medicines and associated legislation during an influenza pandemic (Joint response with other pharmacy bodies)	Department of Health
Health Care and Associated Professions (Miscellaneous Amendments) (No. 2) Order 2008	Department of Health
Research excellence framework	Higher Education Funding Council for England
Science and innovation strategy	Department for Innovation, Universities and Skills
January 2008
NHS Next Stage Review	Department of Health
MLX 346: Amendments to the range of medicines that can be sold, supplied or administered by registered midwives	Medicines and Healthcare products Regulatory Agency
ARM 50 – Request to reclassify a product from P to GSL	Medicines and Healthcare products Regulatory Agency
Responsible pharmacist regulations	Department of Health
EQUIP consultation	Skills for Health
ARM 49 – Request to reclassify a product from POM to P	Medicines and Healthcare products Regulatory Agency
MLX 345: Risk-based inspection programme for good practice inspections	Medicines and Healthcare products Regulatory Agency
December 2007
ARM 48 – Request to reclassify a product from P to GSL	Medicines and Healthcare products Regulatory Agency
November 2007
Needle exchange guidance	National Institute for Health and Clinical Excellence
MLX 343: Proposals to make the sale and supply of products containing more than 720mg pseudoephedrine and 180mg ephedrine subject to a prescription	Medicines and Healthcare products Regulatory Agency
Clinical and cost-effectiveness of interventions in medicines reconciliation	National Institute for Health and Clinical Excellence
ARM 45 – Request to reclassify a product from P to GSL	Medicines and Healthcare products Regulatory Agency
October 2007
Inquiry into the misuse of prescription drugs	All Party Parliamentary Group on Drug Misuse
Fitness to practise: The standard of proof	General Medical Council
Making experiences count: A new approach to responding to complaints	Department of Health
MLX 342: Proposals to amend Section 58 of the Medicines Act 1968 to enable UK pharmacists to dispense POMs prescribed by doctors and dentists registered in EU Member States and Switzerland	Medicines and Healthcare products Regulatory Agency
ARM 44 – Request to reclassify a product from P to GSL	Medicines and Healthcare products Regulatory Agency
September 2007
Chemical substances that can be used in the manufacture of illegal drugs	Home Office
Code of practice for the use of powers to counter NHS fraud and security incidents	Department of Health
Safeguarding Vulnerable Groups Act 2006	Department for Children, Schools and Families
August 2007
Distribution review of horse vaccines and cat flea treatments	Veterinary Medicines Directorate
Clinical guidelines on drug misuse and dependence	National Treatment Agency
HPC Standards of conduct, performance and ethics	Health Professions Council
HPC Guidance on confidentiality	Health Professions Council
July 2007
The European Qualifications (Health and Social Care Professions) Regulations 2007	Department of Health
The European Communities (Recognition of Professional Qualifications) Regulations 2007	Department for Education and Skills
ARM 43 – Request to reclassify a product from POM to P	Medicines and Healthcare products Regulatory Agency
Nominating a consultee for research involving adults who lack capacity to consent	Department of Health
ARM 42 – Request to reclassify a product from P to GSL	Medicines and Healthcare products Regulatory Agency
Health-related information to patients (updated response)	European Commission
Consensual disposal and guidance to fitness to practise rules	General Medical Council
June 2007
Changes to the Misuse of Drugs Regulations 2001 and the Misuse of Drugs Regulations (Northern Ireland)	Home Office
MLX 337: Restricting availability of medicines containing pseudoephedrine and ephedrine by change in legal status from P to POM together with restriction in pack size	Medicines and Healthcare products Regulatory Agency/ Home Office
Provision of information to patients on medicinal products	European Commission
Public health policy	Conservative Research Department
Inhaled corticosteroids for chronic asthma in children	National Institute for Health and Clinical Excellence
MLX 338: Independent prescribing of Controlled Drugs by nurse and pharmacist independent prescribers	Medicines and Healthcare products Regulatory Agency/ Home Office
Performers' list review	Department of Health
MLX 336: Patient group directions	Medicines and Healthcare products Regulatory Agency
May 2007
Inquiry into allergy	House of Lords
Statutory examination for overseas (non-EEA) dentists	General Dental Council
Commissioning framework for health and well-being	Department of Health
Venous thromboembolism guidelines	National Institute for Health and Clinical Excellence
ARM 41 – Request to reclassify a product from POM to P	Medicines and Healthcare products Regulatory Agency
Schizophrenia clinical guidance update	National Institute for Health and Clinical Excellence
April 2007
European credit system for vocational education and training	Department for Education and Skills
March 2007
Guide to good practices for preparation of medicinal products in pharmacies	Pharmaceutical Inspection Convention/ Pharmaceutical Co-operation Scheme
ARM 40 – Request to reclassify a product from P to GSL	Medicines and Healthcare products Regulatory Agency
Possible Reforms of S12(1) of the Medicines Act 1968 and its associated provisions	Medicines and Healthcare products Regulatory Agency
ARM 39 – Request to reclassify a product from POM to P	Medicines and Healthcare products Regulatory Agency
Health in Europe: A Strategic Approach (response from Alliance of UK Health Regulators on Europe - AURE)	European Commission
Compulsory continuing professional development (CPD) for dental care professionals (DCPs)	General Dental Council
February 2007
Review of the MUR Forum	Pharmaceutical Services Negotiating Committee
Smoking cessation programme guidance, consultation on evidence	Centre for Public Health Excellence
Code of practice for promotion of NHS Services	Department of Health
Consultation on common core principles for self care (Joint response with London, Eastern and South East Specialist Pharmacy Services)	Skills for Health
ARM 38: Request to reclassify a product from P to GSL	Medicines and Healthcare products Regulatory Agency
Development of UK-wide regulatory frameworks for public health practitioners	UK Voluntary Register of Public Health Specialists
Medical expert witnesses: delivery of medical expert evidence in family law cases	Department of Health
January 2007
Omalizumab for severe persistent allergic asthma (joint response with UK Clinical Pharmacy Association)	National Institute for Health and Clinical Excellence
Community action on health services (response from Alliance of UK Health Regulators on Europe - AURE)	European Commission
Direction of travel for urgent care (response from national Pharmacy Modernisation Group)	Department of Health
The Food Supplements (England) (Amendment) Regulations 2007	Food Standards Agency
ARM 37: Request to reclassify a product from POM to P	Medicines and Healthcare products Regulatory Agency
December 2006
ARM 36: Request to reclassify a product from P to GSL	Medicines and Healthcare products Regulatory Agency
Community-based interventions to reduce substance misuse	National Institute for Health and Clinical Excellence
November 2006
Clinical guideline: Medicines concordance, scope consultation	National Institute for Health and Clinical Excellence
Review of complaints and disciplinary processes	Bar Standards Board
Prevention of sexually-transmitted infections and reduction of under 18 conceptions	National Institute for Health and Clinical Excellence
Good doctors, safer patients and The regulation of non-medical healthcare professionals	Department of Health
October 2006
Independent prescribing by optometrists	Medicines and Healthcare products Regulatory Agency
Undergraduate medical education	General Medical Council
Commissioning for health and well-being	NHS Networks
Omalizumab for the treatment of uncontrolled asthma	National Institute for Health and Clinical Excellence
Competency framework for shared decision-making with patients	NPC Plus
NICE Citizens Council report on health inequalities	NICE Citizens Council
Draft electronic prescribing functional specification	NHS Connecting for Health
Smoke-free premises and vehicles (joint response with Smoking Control Network)	Department of Health
System for assessing overseas dentists	General Dental Council
Making good medical decisions/Shared decision making	General Medical Council
September 2006
Reform in England to the control of entry system for NHS pharmaceutical contractors	Department of Health
Review of Effectiveness - Community-based interventions for the reduction of substance misuse among vulnerable and disadvantaged young people	National Institute for Health and Clinical Excellence
August 2006
EU study on community pharmacists	Department of Health
MLX 333: Records of prescription only medicines supplied through pharmacies	Medicines and Healthcare products Regulatory Agency
Revised Section 29 Process and Guidelines Document	Council for Healthcare Regulatory Excellence
Tackling nuisance or disturbance behaviour on NHS healthcare premises: a paper for consultation	NHS Security Management Service
European Commission’s draft proposal for amendments to the Animal By-Products Regulation (EC) No 1774/2002	Department for Environment Food and Rural Affairs
Safer Management of Healthcare Waste Consultation Health Technical Memorandum 07- 01	Central Office of Information
July 2006
The Welfare of Animals during transport - consultation on the implementation of EU Regulation 1/2005	Department for Environment Food and Rural Affairs
The new Inspectorate for Justice, Community Safety and Custody	HM Inspectorate of Prisons
June 2006
Pharmacists and Pharmacy Technicians Order 2006	Department of Health
Veterinary medicines Regulations 2006, supporting regulatory impact assessment and veterinary medicines guidance notes	Veterinary Medicines Directorate
Veterinary Medicines Regulations 2006: Proposals for the Administration of Homoeopathic Veterinary Medicinal Products	Veterinary Medicines Directorate
April 2006
HBN 29 - Facilities for medicines management	COI
March 2006
Independent Review of Livestock Movement Rules	Department for Environment, Food and Rural Affairs
Fitness to Practise Draft Rules Consultation	General Dental Council
Modernising the regulation of primary care - NHS (Pharmaceutical Services Supplementary List) and (Pharmaceutical Service) Amendment Regulations 2006	Department of Health
Reform of RICS Regulatory Framework	Royal Institution of Chartered Surveyors
The standard of proof to be adopted by the registration appeals committee and the fitness to practise committee of the General Optical Council	General Optical Council
The General Dental Council (Dental Care Professional Register) draft Rules 2006	General Dental Council
February 2006
ARM 35: Request to reclassify a product from Pom to P	Medicines and Healthcare products Regulatory Agency
Safe Management of Healthcare Waste	Central Office of Information
January 2006
Animal Health and Welfare Strategy	England Implementation Group
A disabled person's guide to becoming a health professional	Health Professions Council
December 2005
HBN 29 - Guidance on Medicines Management within acute hospitals	COI
ARM 34: Request to reclassify a product from P to GSL	Medicines and Healthcare products Regulatory Agency
Amendments to Waste Management Licensing Exemptions relating to Hazardous Waste	Department for Environment, Food and Rural Affairs
Fitness to practise at the point of registration	Nursing & Midwifery Council
Legislative Review 2005	General Osteopathic Council
November 2005
Review of Good Medical Practice - a draft consultation	General Medical Council
Your health, your care, your say: Local listening exercises	Department of Health
Proposals to simplify the reimbursement arrangements for NHS dispensing contractors	Department of Health
Inquiry into the Prescription Charge Scheme	All Party Pharmacy Group Primary Care and Public Health
Strengthened governance arrangements for Safer management of controlled drugs	Department of Health
Towards a European Qualifications Framework for Lifelong Learning	European Commission
October 2005
ARM 33: Request to reclassify a product from P to GSL	Medicines and Healthcare products Regulatory Agency
The Veterinary Medicines Regulations 2005 - Code of Practice for the registration of retail premises and Suitably Qualified Persons (SQPs)	Veterinary Medicines Directorate
Review of the Distribution Category (Legal Classification) of Veterinary Medicinal Products	Veterinary Medicines Directorate
Role for a universal ethical code for scientists	Council for Science and Technology
Modernising the regulation of primary care – NHS (Pharmaceutical Services Supplementary List) Regulations 2005	Department of Health
Proposed Changes to misuse of drugs legislation	Home Office
Code of practice for the pharmaceutical industry and constitution and procedure for PMCPA	The Prescription Medicines Code of Practice Authority
August 2005
ARM 31: Request to reclassify a product from POM to P	Medicines & Healthcare Products Regulatory Agency
Return to practice consultation	Health Professions Council
Changing regulations for paediatric formulations	Medicines & Healthcare Products Regulatory Agency
ARM 30: Request to reclassify a product from POM to P	Medicines & Healthcare Products Regulatory Agency
July 2005
ARM 29: Request to reclassify a product from POM to P	Medicines & Healthcare Products Regulatory Agency
Tuberculosis guideline, First consultation	National Institute for Health and Clinical Exellence
June 2005
General Dental Council Professional Conduct Committee	General Dental Council
May 2005
Proposals to introduce independent prescribing by pharmacists	Medicines & Healthcare Products Regulatory Agency
Proposed changes to misuse of drugs legislation	Home Office
Clinical management of drug dependence in the prisons setting	HM Prison Service/ Department of Health
March 2005
ARM 28: Request to reclassify a product from P to GSL	Medicines & Healthcare Products Regulatory Agency
Gateways to the professions	Department for Education and Skills
MLX 311: Amendments to the Medicines for Human Use (Marketing Authorisations Etc) Regulations 1994	Medicines & Healthcare Products Regulatory Agency
Making the best use of the pharmacy workforce	Department of Health
February 2005
ARM 27: Request to reclassify a product from P to GSL	Medicines & Healthcare Products Regulatory Agency
Framework for standard for post-registration nursing	Nursing and Midwifery Council
January 2005
ARM 25: Request to reclassify a product from POM to P	Medicines & Healthcare Products Regulatory Agency
Request to raise GSL pack size limit for Dulcolax (bisacodyl 5mg) tablets	Medicines & Healthcare Products Regulatory Agency
Access to relevant documents, records and data to counter NHS fraud	Department of Health
December 2004
Models of care for drug misusers	National Treatment Agency for Drug Misuse
Employment of pharmacy support staff in prison healthcare services	Department of Health
November 2004
GMC licensing and revalidation regulations	General Medical Council
Draft statement of common purpose for subject benchmarks for the health and social care professions	Quality Assurance Agency for Higher Education
Study on pharmacogenetics	Royal Society
MLX 309: Implementation of revised EU medicines legislation	Medicines & Healthcare Products Regulatory Agency
October 2004
Community pharmacy contractual framework	Department of Health
Animal by-products	Department for Environment, Food and Rural Affairs
Review of the Special Waste Regulations 1996 in England	Department for Environment, Food and Rural Affairs
Strengthening the General Dental Council	Department of Health
National Health Service Reform and Health Care Professions Act 2002	Council for Healthcare Regulatory Excellence
The General Optical Council (Fitness to Practise) Rules 2005	General Optical Council
Assurance scheme for mobile feed contractors	National Association of Agricultural Contractors
September 2004
Feeding stuffs regulations	Food Standards Agency
Fees for the licensing of veterinary medicinal products	Veterinary Medicines Directorate
CHD national workforce competence framework	Skills for Health
Utility of co-proxamol	Medicines & Healthcare Products Regulatory Agency
Proposals for the introduction of the European Health Insurance card	Department of Health
Investigating patient safety incidents	Department of Health
August 2004
ARM 22: Request to reclassify a product from P to GSL	Medicines & Healthcare Products Regulatory Agency
ARM 21: Request to reclassify a product from P to GSL	Medicines & Healthcare Products Regulatory Agency
Amendments to UFAS codes of practice	Assured Food Standards
Review of veterinary medicines legislation - cost implications	Veterinary Medicines Directorate
MLX 306: Medicines which can be sold, supplied or administered optometrists	Medicines & Healthcare Products Regulatory Agency
Report of an independent review of access to Yellow Card Scheme	Medicines & Healthcare Products Regulatory Agency
July 2004
ABM abattoir and cutting plant standards	Assured British Meat
Legislation on identity cards	Home Office
Professional teaching standards	Universities UK
June 2004
Choosing health? A consultation on improving people's health	Department of Health
ARM 20: Request to reclassify a product from P to GSL	Medicines & Healthcare Products Regulatory Agency
Consultation on EU services directive	Department for Trade and Industry
Draft Denatured Alcohol Regulations 2004	HM Customs and Excise
National Patient Safety Agency R&D strategy: Listening exercise	National Patient Safety Agency
MLX 302: Administration of medicines by paramedics	Medicines & Healthcare Products Regulatory Agency
MLX 299: Regulation of unlicensed herbal remedies in the UK made up to meet the needs of individual patients	Medicines & Healthcare Products Regulatory Agency
Regulation of herbal medicine and acupuncture	Department of Health
Regulation of health care staff in England and Wales	Department of Health
Dementia - scope consultation	National Institute for Clinical Excellence
May 2004
Review of the regulatory framework for legal services in England and Wales	Department for Constitutional Affairs
MLX 300: Review of the Advisory Bodies structure laid down in the Medicines Act 1968	Medicines & Healthcare Products Regulatory Agency
Statutory appeals and statutory review	Department for Constitutional Affairs
Falls guideline - 2nd Consultation	National Institute for Clinical Excellence
Bipolar disorder guideline	National Collaborating Centre for Mental Health, University College London
April 2004
Epilepsy - 2nd Consultation	National Institute for Clinical Excellence
Review of the alert letter system	Department of Health
ARM 19: Request to reclassify a product from P to GSL	Medicines & Healthcare Products Regulatory Agency
Complementary healthcare: a guide for patients	The Prince of Wales's Foundation for Integrated Health
March 2004
Dyspepsia guideline	National Institute for Clinical Excellence
MLX 296: Sale, supply or importation of unlicensed herbal medicinal products for internal use which contain Senecio species	Medicines & Healthcare Products Regulatory Agency
Reforming the NHS complaints procedure: Consultation on draft Regulations	Department of Health
MLX 298: Supplementary prescribing	Medicines & Healthcare Products Regulatory Agency
Reforming the NHS complaints procedure: Consultation on CHAI's proposals for the independent stage	Commission for Health Improvement
No secrets: Guidance on developing and implementing multi-agency policies and procedures to protect vulnerable adults from abuse	Department of Health
February 2004
Self-harm - 2nd Consultation	National Institute for Clinical Excellence
Draft Scope Consultation on Obesity	National Institute for Clinical Excellence
NICE Anxiety - 2nd Consultation	National Institute for Clinical Excellence
January 2004
Health Technology Appraisal - Statins	National Institute for Clinical Excellence
Type I diabetes - 2nd Consultation	National Institute for Clinical Excellence
Independent Review of Access to Yellow Card Data	Steering Committee for the Review of Access to Yellow Card Data
Criminal Records Bureau: Regulations under the Police Act 1977	Home Office
ARM 18: Request to reclassify a product from POM to P	Medicines & Healthcare Products Regulatory Agency
ARM 17: Request to reclassify a product from POM to P	Medicines & Healthcare Products Regulatory Agency

• Home
• Help
• Contact us
• Accessibility
• Complaints
• Links
• Site map
• Terms & Conditions
• Freedom of Information
• Search
• Register search

• © 2010
• Royal Pharmaceutical Society of Great Britain
• 1 Lambeth High Street London SE1 7JN
• 020 7735 9141
• www.rpsgb.org